NovaBay Pharmaceuticals, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-26. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 58 people.
| Name | Role | Location |
|---|---|---|
| Xiaoyan Alex Liu | Director | Emeryville, CA |
| Massimo Alex Radaelli | Director | Emeryville, CA |
| Mijia Alex Wu | Director | Emeryville, CA |
| Roy J Wu | Executive Officer | Emeryville, CA |
| Gail Maderis | Director | Redwood City, CA |
| MIJIA (BOB) WU | Director | EMERYVILLE, CA |
| SWAN SIT | Director | EMERYVILLE, CA |
| PAUL FREIMAN | Director | EMERYVILLE, CA |
| JULIE GARLIKOV | Director | EMERYVILLE, CA |
| JUSTIN HALL | Director | EMERYVILLE, CA |
| JUSTIN HALL | Executive Officer | EMERYVILLE, CA |
| TOMMY LAW | Executive Officer | EMERYVILLE, CA |
| YENYOU (JEFF) ZHENG | Director | EMERYVILLE, CA |
| YONGXIANG (SEAN) ZHENG | Director | EMERYVILLE, CA |
| Andrew Jones | Executive Officer | Riverside, MO |
| JEFFREY KUNIN | Executive Officer | KANSAS CITY, MO |
| AUDREY KUNIN | Director | KANSAS CITY, MO |
| AUDREY KUNIN | Executive Officer | KANSAS CITY, MO |
| Mark Sieczkarek | Director | El Segundo, CA |
| Gail E Maderis | Director | Berkeley, CA |
| YENYOU (JEFF) E ZHENG | Director | EMERYVILLE, CA |
| PAUL E FREIMAN | Director | EMERYVILLE, CA |
| AUDREY M KUNIN | Executive Officer | KANSAS CITY, MO |
| SWAN E SIT | Director | EMERYVILLE, CA |
| XINZHOU (PAUL) E LI | Director | EMERYVILLE, CA |
Showing 15 of 18 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-01-27 | D | $134.0M | $134.0M |
| 2024-06-28 | D | $226K | $226K |
| 2024-04-05 | D | $665K | $665K |
| 2024-01-04 | D | $555K | $555K |
| 2023-05-18 | D | $3.0M | $3.0M |
| 2022-09-23 | D | $3.3M | $3.3M |
| 2022-09-23 | D | $2.1M | $2.1M |
| 2021-11-17 | D | $15.0M | $15.0M |
| 2020-07-31 | D | $6.8M | — |
| 2020-05-22 | D | $1.7M | $1K |
| 2020-05-01 | D | — | — |
| 2019-08-26 | D | $4.2M | $4.2M |
| 2019-08-26 | D | $2.7M | $2.7M |
| 2019-07-03 | D | $2.4M | $2.4M |
| 2018-02-14 | D | $6.0M | $6.0M |